Loading clinical trials...
Loading clinical trials...
Remimazolam Besylate Versus Propofolfor Sedation of Postcardioperative Patients in Intensive Care Unit: a Prospective,Single-center,Randomized Non-inferior Trial
Conditions
Interventions
Remimazolam
Propofol
Locations
1
China
First afflilated hospital of zhejiang university school of medicine
Hangzhou, Zhejiang, China
Start Date
February 10, 2025
Primary Completion Date
April 30, 2025
Completion Date
May 31, 2025
Last Updated
February 18, 2025
NCT07440342
NCT06436638
NCT07461376
NCT07269808
NCT07000526
NCT07222007
Lead Sponsor
First Affiliated Hospital of Zhejiang University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions